Company: INDP
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001641172-25-023333
Chunk: 32

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 1
Chunk 32
---
INDAPTUS
THERAPEUTICS, INC.

Unaudited
Condensed Consolidated Balance Sheets

    June 30, 2025  
    December 31, 2024 
  
    Assets 

    Current assets: 

    Cash and cash equivalents 
    $6,157,701  
    $5,786,753 
  
    Prepaid expenses and other current assets 
     255,357  
     831,577 

    Total current assets 
     6,413,058  
     6,618,330 

    Non-current assets: 

    Right-of-use asset 
     33,577  
     82,175 
  
    Other assets - deposits to third parties 
     392,572  
     638,251 

    Total non-current assets 
     426,149  
     720,426 

    Total assets 
    $6,839,207  
    $7,338,756 

    Liabilities and stockholders’ equity (deficit) 

    Current liabilities: 

    Accounts payable and other current liabilities 
    $1,975,687  
    $3,309,717 
  
    Operating lease liability, current portion 
     34,373  
     84,164 
  
    Fair value of convertible promissory notes (Note 7) 
     6,502,503  
     - 

    Total current liabilities 
     8,512,563  
     3,393,881 

    Commitments and contingencies (Note 8) 
     -  
     - 

    Stockholders’ equity: 

    Common stock: $0.01 par value,
    200,000,000 shares authorized as of June
    30, 2025 and December 31, 2024; 604,963
    shares issued and outstanding as of June 30, 2025 and 428,799
    shares issued and outstanding as of December 31, 2024* 
     6,050  
     4,288 
  
    Preferred stock: $0.01 par value, 5,000,000 shares authorized as of June 30, 2025 and December 31, 2024; no shares issued or outstanding 
     -  
     -